Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of September 15-21, 2023.

He highlights research in advanced urothelial carcinoma, intrahepatic cholangiocarcinoma, KRAS mutations and patient quality of life.

Dr Morgan also spotlights an Annals of Oncology paper for the NATALEE study which evaluates adding ribociclib to endocrine therapy in early breast cancer.

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer